IRIS Accounts Production v24.3.2.46 OC437281 designated member 1.6.23 31.5.24 31.5.24 0 0 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhOC4372812023-05-31OC4372812024-05-31OC4372812023-06-012024-05-31OC4372812022-05-31OC4372812022-06-012023-05-31OC4372812023-05-31OC437281ns15:EnglandWales2023-06-012024-05-31OC437281ns14:PoundSterling2023-06-012024-05-31OC437281ns10:PartnerLLP12023-06-012024-05-31OC437281ns10:LimitedLiabilityPartnershipLLP2023-06-012024-05-31OC437281ns10:Micro-entities2023-06-012024-05-31OC437281ns10:AuditExemptWithAccountantsReport2023-06-012024-05-31OC437281ns10:LimitedLiabilityPartnershipsSORP2023-06-012024-05-31OC437281ns10:FullAccounts2023-06-012024-05-31OC437281ns10:RegisteredOffice2023-06-012024-05-31
REGISTERED NUMBER: OC437281 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2024

FOR

HEX THERAPEUTICS LLP

HEX THERAPEUTICS LLP (REGISTERED NUMBER: OC437281)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024










Page

Report of the Accountants 1

Balance Sheet 2


HEX THERAPEUTICS LLP

REPORT OF THE ACCOUNTANTS TO THE MEMBERS OF
HEX THERAPEUTICS LLP


The following reproduces the text of the report prepared for the members in respect of the LLP's annual unaudited financial statements. In accordance with the Companies Act 2006, the LLP is only required to file a Balance Sheet. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 May 2024 set out on pages two to four and you consider that the LLP is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Ashford Green Limited
Electric House
Ninian Way
Wilnecote
Tamworth
Staffordshire
B77 5DE


12 February 2025

HEX THERAPEUTICS LLP (REGISTERED NUMBER: OC437281)

BALANCE SHEET
31 MAY 2024

2024 2023
£    £   
CURRENT ASSETS 1 1
NET CURRENT ASSETS 1 1
TOTAL ASSETS LESS CURRENT
LIABILITIES

1

1

LOANS AND OTHER DEBTS DUE TO MEMBERS 1 1

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Hex Therapeutics LLP is registered in England and Wales. The LLP's registered number and registered office address are as below:

Registered number: OC437281

Registered office: Electric House
Ninian Way
Wilnecote
Tamworth
Staffordshire
B77 5DE

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2023 - NIL).



The LLP is entitled to exemption from audit under Section 477 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 for the year ended 31 May 2024.

The members acknowledge their responsibilities for:
(a)ensuring that the LLP keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the LLP as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 relating to financial statements, so far as applicable to the LLP.

HEX THERAPEUTICS LLP (REGISTERED NUMBER: OC437281)

BALANCE SHEET - continued
31 MAY 2024


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

The financial statements were approved by the members of the LLP and authorised for issue on 12 February 2025 and were signed by:





L Reilly - Designated member